Endovascular Treatment of Aorto-iliac Occlusions

Launched by CLINICAL CENTRE OF SERBIA · Jan 29, 2019

Keywords

ClinConnect Summary

Endovascular treatment has been increasingly applied as a therapeutic option for aorto-iliac occlusive disease during the last decade, becoming the first-line treatment for many of the Trans-Atlantic Inter-Society Consensus document II (TASC II) categories. TASC II document in 2007 stated endovascular treatment as the method of choice up to type B occlusions and surgery for low-risk patients with type C and D occlusions, emphasizing that the patient's comorbidities as well as the operator's long-term success rates should be included in the decision-making process.

Revision of TASC II docum...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient has aorto-iliac occlusions type B, C \& D according to TASC-II classification
• • Patient suffers from severe claudication (Rutherford 3) or critical limb ischemia (Rutherford 4 and 5)
• • Patients fulfilling criteria for endovascular treatment of aorto-iliac occlusion according to criteria of the participating centres.
• Exclusion Criteria:
• • Patients with associated abdominal or iliac aneurysm, restenotic lesions, acute thrombi or dissections,
• • Patients who experienced an initial technical failure